After weeks of investigations, the European Medicines Agency (EMA) says there is the “possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within two weeks of vaccination” with the AstraZeneca coronavirus vaccine. Overnight, the regulator also said that the benefits of the vaccine outweighed the risk. The World Health Organisation says although the blood clot link was “plausible”, it was “not confirmed” and that cases of clots were “very rare” among 200 million people who have been vaccinated with the AstraZeneca jabs globally. Still, the UK’s vaccine advisory body said that under-30yos should be offered a different vaccine. Analysts said it will be up to individual governments to outline how they will respond to the report. Yesterday, PM Scott Morrison again outlined what the government’s done to get 3.1 million contracted doses of the AstraZeneca vaccine sent to Oz from Europe in the face of ongoing criticism that the rollout has been slow and chaotic.